
Johns Hopkins Stem Cell Treatment Cures 95% of Sickle Cell
A new stem cell transplant developed at Johns Hopkins has cured sickle cell disease in 95% of patients, using half-matched donors like parents or siblings. The breakthrough means nearly every sickle cell patient can now access a cure that also preserves fertility.














_-_Illustration_-_Andrii_Vodolazhskyi_M1_4bb73c51d46c449285a21e8af28684d6-620x480.jpg)

